Wegovy, in conjunction with diet and exercise, is authorized to assist adults and children aged 12 years and older struggling with obesity, or some adults grappling with excess weight alongside weight-related medical conditions, in their efforts to lose weight and maintain their weight loss
specializing in weight management, GLP-1 medication nutrition therapy, bariatric surgery, digestive health, and sustainable behavior change Leah Jones, MD Board-certified in Internal Medicine and Obesity Medicine Katherine Austin, MD, MPH, FAAP, FRCP(C) Board-certified in Pediatrics and Adolescent Medicine Heather Cecchini, MSN, APRN, ANP-C Board-certified Adult-Primary Care Nurse Practitioner Clete Barrick, MD Board-certified in Internal Medicine and Obesity Medicine Caitlin Camill, RDN, CDCES Certified Diabetes Care and Education Specialist
FDA declared both shortages resolved in early 2026
GLP-1s, used to treat obesity, diabetes and heart problems, delay gastric emptying, and residual food or liquid in the stomach at the time of surgery with general anesthesia, may increase the risk for serious complications including aspiration
doi: 10.1016/j.bbrc.2015.01.098 184 SpielmanLJGibsonDLKlegerisA
A A 2014 review of older research suggests that MCT oil could promote the release of two hormones that help people feel full when eating: peptide YY and leptin